Significant interest in drug discovery and therapeutic breakthroughs has been triggered by the revival of plant pharmacological research. Although plant-derived chemicals have been employed in contemporary medicine for centuries, technological improvements have markedly accelerated their research and development. This article provides a critical examination of the rapid rise of plant-based medicine by assessing its scientific, economic, and ethical consequences to establish the justification behind this developing field. We examine current research trends, issues related to standardization and bioavailability, and the relative efficacy of synthetic and plant-based medications. The importance of biotechnology, artificial intelligence, and sustainable practices in maximizing the development of plant-derived drugs is also discussed. Despite ongoing challenges, interdisciplinary approaches could improve the legitimacy and relevance of plant pharmacology. Ultimately, we assess whether this research trajectory is scientifically justified and economically viable, offering insights into its future potential.
Srinivasa et al. (Sat,) studied this question.